Diagnosis of Diabetes Insipidus: Is the Water Deprivation Test Necessary?

Several different diagnostic approaches can be used to confirm and distinguish central diabetes insipidus, nephrogenic diabetes insipidus and primary (psychogenic) polydipsia. The water deprivation test is generally considered by most authorities to be the best diagnostic test to differentiate between these disorders. However, the water deprivation test has many disadvantages, which include the following:

• The test is very labor intensive
  
• The test can be difficult to perform correctly
  
• The test is quite unpleasant for the dog or cat
  
• The test relies heavily on repeated emptying of the bladder
  
• The test can lead to untoward complications
  
• The test can lead to misdiagnosis in some animals

A simpler and more practical method of diagnosis that I recommended as an alternative to water deprivation testing is evaluation of the clinical response to a closely monitored therapeutic trial with the vasopressin analogue, desmopressin (DDAVP).

Use of the therapeutic trial with desmopressin as a diagnostic test 

This approach is less complicated and time consuming than the water deprivation test, and is certainly easier on the cat. The cost of the two approaches varies according to circumstances but is often comparable. Again, before a desmopressin trial is initiated, it is extremely important to rule out all other common causes of polyuria and polydipsia, limiting the differential diagnosis to central diabetes insipidus, primary nephrogenic diabetes insipidus, and primary (psychogenic) polydipsia. For further information, see my previous blog posts.

To perform the test, the owner should first measure the animal's 24-hour water intake for 2 to 3 days before desmopressin is initiated, allowing free-choice water intake. The dog or cat is then treated with therapeutic dosages of desmopressin (see our next post, What Drugs Do We Use to Treat Diabetes Insipidus).

For the purposes of this test, the desmopressin ideally is administered subcutaneously at the dosage of 1.0 to 4.0 μg twice daily for a period of 5 to 7 days. If subcutaneous injections cannot be given, administration of desmopressin by the conjunctival (1-5 drops twice daily) or oral routes (0.05-2.0 mg twice daily) can be used instead. During this treatment period, the owner should continue to measure the animal’s daily water intake and monitor the degree of urine output.

A dramatic reduction in water intake (>50% of pre-treatment measurements) and polyuria strongly suggests a diagnosis of central diabetes insipidus, whereas a lack of any reduction in polydipsia and polyuria is most consistent with primary nephrogenic diabetes insipidus. With more prolonged treatment, water consumption and urine output should completely normalize in dogs and cats with central diabetes insipidus.

In any older dog or cat that develops diabetes insipidus, one should consider pituitary imaging with computerized tomography or magnetic resonance imaging to exclude a pituitary mass. This is especially true if the affected animal has associated neurological signs.




Computerized tomography (CT) image of the brain of a cat with diabetes insipidus. Note the very large pituitary tumor invading the hypothalamus.